Zacks Investment Research·1d ago
Can MetLife's Group Benefits Segment Maintain Its Momentum?MET's Group Benefits earnings jump 25% in Q2 2026, fueled by stronger underwriting and demand, but some mortality gains may fade.
MetLife's core underwriting remains resilient, with combined ratios consistently between 89.1% and 95.3% over the past ten quarters, and Q2 2026 operating cash flow covering net income by 3.03x. However, reported EPS of $2.43 missed consensus by $0.10 in Q2 20...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has been erratic, with a 9.9% year-over-year increase in Q2 2026 but a 7.7% decline in Q3 2025, while the combined ratio remained stable at 94.5% in Q2 2026, indicating consistent underwriting profitability.
MetLife’s five‑segment structure—insurance, annuities, employee benefits, asset management, and group benefits—provides earnings stability and diversification. The company’s scale and wide product mix help it weather market volatility.
VII is expected to rebound from 25% of normal in 2023 to 75% in 2024, adding roughly $300‑$325 million to earnings. This recovery boosts profitability and supports future growth.
Voluntary benefits in the Group Benefits segment are expanding, and retirement spreads are improving, underscoring MetLife’s strong market positioning. The Asia segment contributes about 25% of earnings, with leading positions in Mexico and Chile.
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $2.43+5.7% vs $2.30 | $19.1B-3.0% vs $19.7B |
Q2 2026 May 6, 2026 | $2.42+6.6% vs $2.27 | $19.7B+1.0% vs $19.5B |
Q1 2026 Feb 4, 2026 | $2.58+10.3% vs $2.34 | $23.8B-12.5% vs $27.2B |
Q4 2025 Nov 5, 2025 | $2.34+1.3% vs $2.31 | $16.9B-9.4% vs $18.6B |
MET's Group Benefits earnings jump 25% in Q2 2026, fueled by stronger underwriting and demand, but some mortality gains may fade.
Life insurers generally benefit from higher rates, but there are some negatives to consider.
Record annuity demand creates opportunities for Prudential, Principal Financial and MetLife as retirement needs and pension solutions grow.
MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced the close of Galaxy 38 CLO, Ltd.
Benchmark MET against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for MetLife, Inc. (MET)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $97.20 | $62.54B | 20.25 | 10.22% | 4.38% | 11.93% | 2.33% | |
| $117.59 | $40.8B | 11.51 | -13.74% | 5.93% | 11.2% | — | |
| $41.08 | $7.86B | 7.03 | 1.24% | 12.18% | 21.99% | — | |
| $94.46 | $14.95B | 22.07 | 2.07% | 5.3% | 6.43% | — | |
| $113.92 | $24.61B | 21.70 | -3.11% | 9.86% | 12.44% | — | |
| $52.27 | $14.27B | -10.82 | -6.21% | -8.72% | -51.38% | — |
MetLife, Inc. (MET) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
MetLife, Inc. (MET) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jun 29, 2026·SEC
Jun 22, 2026·SEC
Get notified when MET posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MetLife, Inc. (MET) stock FAQ — growth, dividends, profitability & financials explained
MetLife, Inc. (MET) grew revenue by 10.2% over the past year. This is steady growth.
Yes, MetLife, Inc. (MET) is profitable, generating $3.63B in net income for fiscal year 2025 (4.4% net margin).
Yes, MetLife, Inc. (MET) pays a dividend with a yield of 2.33%. This makes it attractive for income-focused investors.
MetLife, Inc. (MET) has a return on equity (ROE) of 11.9%. This is reasonable for most industries.
MetLife, Inc. (MET) has a combined ratio of 94.0%. A ratio below 100% indicates underwriting profitability.
